Featured News
'Medical Food' May Slow Brain Atrophy in Patients With Alzheimer's and Related Disorders
Taking a “medical food” product (CerefolinNAC, Nestlé Health Science–Pamlab, Inc) to treat hyperhomocysteinemia (HHcy) may delay the rate of brain atrophy in patients with Alzheimer’s disease and related disorders (ADRD), new research suggests. In a study of 67 participants, those with both HHcy and ADRD who took the L-methylfolate, methylcobalamin, and Nacetylcysteine product for 2 … Read More